Celator Pharmaceuticals, Inc. (Nasdaq: CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that Scott Jackson, Chief Executive Officer,...

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum,...

Synthetic Biologics, Inc. (NYSE MKT: SYN), a clinical stage company focused on developing therapeutics to protect the gut microbiome, announced today that Jeff Riley, CEO, is scheduled to present...

PowerSecure International, Inc. (NYSE: POWR) will present at the 18th Annual Needham Growth Conference at the New York Palace hotel in New York City at 4:50 p.m. ET on Wednesday, January 13, 2016....

CES Booth #13228 -- Vivitar today announced a major rebranding and expansion of its consumer electronics portfolio designed to boost the brand's grab 'n go shelf appeal for the millennial...